Advances in Managing Eosinophilic Esophagitis: Tips for the Practicing Clinician
![](https://cme.tarsusmedicaleducation.com/sites/default/files/styles/course_image_teaser/public/course/2023-07/Advances%20in%20Managing%20Eosinophilic%20Esophagitis%20071223_800x450%20copy%20%281%29.jpg?itok=-D5XaSXO)
Eosinophilic esophagitis (EoE), a chronic, debilitating illness that is mediated via cells of the immune system (eosinophils) eliciting T-helper 2 (Th2) cell mediated inflammation, affects several people globally and imparts significant impact on the quality of life (QoL) o
Category
- TME
Format
- Self-study / Enduring
- Webinar recorded
Credits
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Participation
AhR Agonists for Psoriasis: A Novel Mechanism for Treatment of PsO
![](https://cme.tarsusmedicaleducation.com/sites/default/files/styles/course_image_teaser/public/course/2023-08/AhR%20Agonists%20for%20Psoriasis%20A%20Novel%20Mechanism%20082223_800x450%20copy%20%282%29.jpg?itok=ZqK7hijp)
Psoriasis is a difficult disease to manage due to a variety of factors including fluctuations in disease severity, limited treatment options, and a limited understanding of the pathogenesis of disease.
Category
- LivDerm
- TME
Format
- Self-study / Enduring
Credits
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation
The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis
![](https://cme.tarsusmedicaleducation.com/sites/default/files/styles/course_image_teaser/public/course/2024-05/Individualizing%20Treatment%20for%20Patients%20with%20Chronic%20Kidney%20050724.ai_1200x630.png?itok=P7wYqiSM)
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects an estimated 25-30% of people in the United States and can often progress to Metabolic dysfunction-associated steatohepatitis (MASH) and cirrhosis.
Category
- CMHC
- TME
Format
- Self-study / Enduring
Credits
- 0.75 ACPE Pharmacy
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
- 0.75 Participation